Financing co-led by Samsara Biocapital and Enavate Sciences, with participation from Pfizer Ventures and Regeneron Ventures in addition to other new and existing investors Normunity’s lead program is a novel T cell engager against a…
December 11, 2024 07:00 AM Eastern Standard Time NEW HAVEN, Conn.–(BUSINESS WIRE)–Veradermics, a late clinical-stage aesthetics and dermatology-focused biopharmaceutical company developing first-in-class therapeutics for common dermatologic conditions, announced today the closing of a $75 million…
According to filings with the U.S. Securities and Exchange Commission, Halda Therapeutics is raising up to $126,471,316.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Scott Phillips played a…
Six premier investors join syndicate for Series B extension to fund clinical trials of RIPTAC drug candidates for prostate cancer and breast cancer Initial clinical trial for first-in-class RIPTAC therapeutic in patients with metastatic castration-resistant…
According to filings with the U.S. Securities and Exchange Commission, Halda Therapeutics is raising up to $36,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Scott Phillips played a…
May 30, 2024 06:00 AM Pacific Daylight Time NEW HAVEN, Conn.–(BUSINESS WIRE)–Weave Bio, an AI-native life sciences platform company, announced the public release of its flagship offering, AutoIND, and seed funding of $10M co-led by Innovation…
According to filings with the U.S. Securities and Exchange Commission, Quantum Circuits is raising up to $27,000,000.00 in new funding. Sources indicate that as part of senior management President, Ray Smets played a key role…
According to filings with the U.S. Securities and Exchange Commission, Purpose Built Ventures Studio is raising up to $6,000,000.00 in new funding. Sources indicate that as part of senior management Senior Executive, Miles Lasater played…
According to filings with the U.S. Securities and Exchange Commission, Inbox Health is raising $22,499,997.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Blake Walker played a key role…
New Haven, CT – According to filings with the U.S. Securities and Exchange Commission, CoreChain Technologies is raising $5,759,533.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Christopher Aguas played…